Disruptive Ceo Nation

CytoReason is supporting some of the largest pharma companies and research institutes with their boldest attempts to improve people lives through improved clinical design and speeding the discovery of new life-saving drugs. Using the knowledge the world has accumulated to intelligently augment clients’ data and to identify patterns within it and generate a system-level understanding of immunity. These patterns then become powerful tools for explaining, predicting and optimizing outcomes proving guidance in both drug discovery and clinical trials. I spoke with David from his office in TelAviv and here is some of what we touched on: - What it means to be the first cell-centered computational model for human disease. - How CytoReason's massive database and AI-led platform supports the pharma and the biotech space to make decisions on what drug to give to what patients. - It's not one company, it's not one person, it's not the brilliance of one researcher or one invention but rather a long, long, long chain of